Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study

References

• Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J (1985) Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J. Biol. Chem. 260: 7094–7101.
   PubMed Web of Science ®Google Scholar
• Benovic JL, Stone WC, Huebner K, Croce C, Caron MG, Lefkowitz RJ (1991) cDNA cloning and chromosomal localization of the human beta-adrenergic receptor kinase. FEBS Lett. 283: 122–126.
   PubMed Web of Science ®Google Scholar
• Chelmicka-Schorr E, Arnason BG, Holshouser SJ (1980) C-6 glioma growth in rats: suppression with a beta-adrenergic agonist and a phosphodiesterase inhibitor. Ann. Neurol. 8: 447–449.
   Google Scholar
• Chiesa IJ, Castillo LF, Luthy IA (2008) Contribution of alpha2-adrenoceptors to the mitogenic effect of catecholestrogen in human breast cancer MCF-7 cells. J. Steroid Biochem. Mol. Biol. 110: 170–175.
   PubMed Web of Science ®Google Scholar
• Cho-Chung YS, Clair T, Tagliaferri P, Ally S, Katsaros D, Tortora G (1989) Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest. 7: 161–177.
   PubMed Web of Science ®Google Scholar
• D'Amico C, Crescimanno M, Armata MG, Leonardi V, Palazzoadriano M, D'Alessandro N (1992) Beta-adrenergic influences on doxorubicin-sensitive or -resistant P388 leukemia cells. Anticancer Res. 12: 2253–2256.
   Google Scholar
• Drell TL IV, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F (2003) Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res. Treat. 80: 63–70.
   PubMed Web of Science ®Google Scholar
• Elferink JG, VanUffelen BE (1996) The role of cyclic nucleotides in neutrophil migration. Gen. Pharmacol. 27: 387–393.
   PubMedGoogle Scholar
• Entschladen F, Drell TL 4th, Lang K, Joseph J, Zaenker KS (2005) Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis development. Curr. Pharm. Des. 11: 403–411.
   PubMed Web of Science ®Google Scholar
• Entschladen F, Lang K, Drell TL, Joseph J, Zaenker KS (2002) Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol. Immunother. 51: 467–482.
   PubMed Web of Science ®Google Scholar
• Fuchs R, Stelzer I, Haas HS, Leitinger G, Schauenstein K, Sadjak A (2009) The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells. Ann. Hematol. 88: 989–997.
   Google Scholar
• Green DR, Evan GI (2002) A matter of life and death. Cancer Cell 1: 19–30.
   PubMed Web of Science ®Google Scholar
• Hughes RJ, Howard MJ, Allen JM, Insel PA (1991) Decreased beta 2-adrenergic receptor mRNA expression in receptor-deficient S49 lymphoma cells. Mol. Pharmacol. 40: 974–979.
   PubMed Web of Science ®Google Scholar
• Jin Z, Gao F, Flagg T, Deng X (2004a) Nicotine induces multi-site phosphorylation of Bad in association with suppression of apoptosis. J. Biol. Chem. 279: 23837–23844.
   PubMed Web of Science ®Google Scholar
• Jin Z, Gao F, Flagg T, Deng X (2004b) Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J. Biol. Chem. 279: 40209–40219.
   PubMed Web of Science ®Google Scholar
• Johnson M (2001) Beta2-adrenoceptors: mechanisms of action of beta2-agonists. Paediat. Respir. Rev. 2: 57–62.
   PubMedGoogle Scholar
• Kanda H, Ishii K, Ogura Y, Imamura T, Kanai M, Arima K (2008) Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest. Int. J. Cancer 122: 444–451.
   PubMed Web of Science ®Google Scholar
• Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS (1987) cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 84: 46–50.
   PubMed Web of Science ®Google Scholar
• Kondratenko TY, Zacharova IV, Kuzina NV, Katukov VY, Severin ES, Kornilova ZC (1993) Alterations in human lung adrenergic receptors in cancer. Biochem. Mol. Biol. Int. 29: 123–130.
   Google Scholar
• Lang K, Drell TL, 4th, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS (2004) Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int. J. Cancer 112: 231–238.
   PubMed Web of Science ®Google Scholar
• Lange-Carter CA, Droms KA, Vuillequez JJ, Malkinson AM (1992) Differential responsiveness to agents which stimulate cAMP production in normal versus neoplastic mouse lung epithelial cells. Cancer Lett. 67: 139–144.
   Google Scholar
• Liou SF, Lin HH, Liang JC, Chen IJ, Yeh JL (2009) Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis. Toxicology 256: 13–24.
   Google Scholar
• Luthy IA, Bruzzone A, Pinero CP, Castillo LF, Chiesa IJ, Vazquez SM (2009) Adrenoceptors: non conventional target for breast cancer? Curr. Med. Chem. 16: 1850–1862.
   PubMed Web of Science ®Google Scholar
• Maestroni GJ (2000) Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J. Immunol. 165: 6743–6747.
   PubMedGoogle Scholar
• Martinez JA, Corbalan MS, Sanchez-Villegas A, Forga L, Marti A, Martinez-Gonzalez MA (2003) Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. J. Nutr. 133: 2549–2554.
   PubMed Web of Science ®Google Scholar
• Masur K, Niggemann B, Zanker KS, Entschladen F (2001) Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 61: 2866–2869.
   PubMed Web of Science ®Google Scholar
• Meinhardt G, Wendtner CM, Hallek M (1999) Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J. Mol. Med. 77: 282–293.
   PubMed Web of Science ®Google Scholar
• Moore MA (2001) The role of chemoattraction in cancer metastases. Bioessays 23: 674–676.
   Google Scholar
• Murphy PM (2001) Chemokines and the molecular basis of cancer metastasis. N. Engl. J. Med. 345: 833–835.
   PubMed Web of Science ®Google Scholar
• Narita S, Shibata O, Waki S, Egashira K, Suzuki T (1973) Adrenaline and noradrenaline secretion of the adrenal gland in conscious dogs in response to pilocarpine and nicotine. Tohoku J. Exp. Med. 110: 303–305.
   Google Scholar
• Palm D, Lang K, Niggemann B, Drell TL 4th, Masur K, Zaenker KS (2006) The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int. J. Cancer 118: 2744–2749.
   PubMed Web of Science ®Google Scholar
• Park PG, Merryman J, Orloff M, Schuller HM (1995) Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease. Cancer Res. 55: 3504–3508.
   Google Scholar
• Paul-Eugene N, Dugas B, Gordon J, Kolb JP, Cairns JA, Paubert-Braquet M (1993) Beta 2-adrenoceptor stimulation augments the IL-4-induced CD23 expression and release and the expression of differentiation markers (CD14, CD18) by the human monocytic cell line, U 937. Clin. Exp. Aller. 23: 317–325.
   Google Scholar
• Pitcher J, Lohse MJ, Codina J, Caron MG, Lefkowitz RJ (1992) Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. Biochemistry 31: 3193–3197.
   PubMed Web of Science ®Google Scholar
• Qing F, Hayes MJ, Rhodes CG, Krausz T, Fountain SW, Burke MM (1996) Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography. Thorax 51: 727–732.
   Google Scholar
• Quackenbush J (2002) Microarray data normalization and transformation. Nat. Genet. 32 Suppl.: 496–501.
   PubMedGoogle Scholar
• Sastry KS, Karpova Y, Prokopovich S, Smith AJ, Essau B, Gersappe A (2007). Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J. Biol. Chem. 282: 14094–14100.
   PubMed Web of Science ®Google Scholar
• Schuller HM, Tithof PK, Williams M, Plummer H 3rd (1999) The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res. 59: 4510–4515.
   PubMed Web of Science ®Google Scholar
• Shang ZJ, Liu K, Liang de F (2009) Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. J. Oral Pathol. Med. 38: 371–376.
   PubMed Web of Science ®Google Scholar
• Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY (2008) Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro. World J. Gastroenterol. 14: 2358–2363.
   PubMed Web of Science ®Google Scholar
• Sheppard JR, Gormus R, Moldow CF (1977) Catecholamine hormone receptors are reduced on chronic lymphocytic leukaemic lymphocytes. Nature 269: 693–695.
   PubMed Web of Science ®Google Scholar
• Silverman EK, Kwiatkowski DJ, Sylvia JS, Lazarus R, Drazen JM, Lange C (2003) Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J. Aller. Clin. Immunol. 112: 870–876.
   PubMed Web of Science ®Google Scholar
• Smyth GK, Yang YH, Speed T (2003) Statistical issues in cDNA microarray data analysis. Methods Mol. Biol. 224: 111–136.
   PubMedGoogle Scholar
• Strader CD, Candelore MR, Hill WS, Sigal IS, Dixon RA (1989). Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. J. Biol. Chem. 264: 13572–13578.
   PubMedGoogle Scholar
• Wallukat G (2002) The beta-adrenergic receptors. Herz 27: 683–690.
   PubMed Web of Science ®Google Scholar
• Wang H, Hao B, Chen X, Zhao N, Cheng G, Jiang Y (2006). Beta-2 adrenergic receptor gene (ADRB2) polymorphism and risk for lung adenocarcinoma: a case-control study in a Chinese population. Cancer Lett. 240: 297–305.
   Google Scholar
• Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucl. Acids Res. 30: e15.
   PubMed Web of Science ®Google Scholar